192 related articles for article (PubMed ID: 567284)
1. Subsensitivity of striatal and mesolimbic dopamine target cells after repeated treatment with apomorphine dipivaloyl ester.
Scatton B; Worms P
Naunyn Schmiedebergs Arch Pharmacol; 1978 Jul; 303(3):271-8. PubMed ID: 567284
[TBL] [Abstract][Full Text] [Related]
2. Tolerance to stereotyped behaviour and to decrease in striatal homovanillic acid levels after repeated treatment with apomorphine dipivaloyl ester.
Worms P; Scatton B
Eur J Pharmacol; 1977 Oct; 45(4):395-6. PubMed ID: 562764
[No Abstract] [Full Text] [Related]
3. Tolerance to increases in striatal acetylcholine concentrations after repeated administration of apomorphine dipivaloyl ester.
Scatton B; Worms P
J Pharm Pharmacol; 1979 Dec; 31(12):861-3. PubMed ID: 43377
[No Abstract] [Full Text] [Related]
4. Definition of the in-vivo accumulation of [3H]spiperone in brain using haloperidol and sulpiride to determine functional dopamine receptor occupation.
Chivers JK; Reavill C; Jenner P; Marsden CD
J Pharm Pharmacol; 1988 Sep; 40(9):613-9. PubMed ID: 2907027
[TBL] [Abstract][Full Text] [Related]
5. Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol.
Asper H; Baggiolini M; Burki HR; Lauener H; Ruch W; Stille G
Eur J Pharmacol; 1973 Jun; 22(3):287-94. PubMed ID: 4738903
[No Abstract] [Full Text] [Related]
6. Differential effects of proglumide on mesolimbic and nigrostriatal dopamine function.
Csernansky JG; Glick S; Mellentin J
Psychopharmacology (Berl); 1987; 91(4):440-4. PubMed ID: 3108924
[TBL] [Abstract][Full Text] [Related]
7. Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment.
Nishikawa T; Mataga N; Takashima M; Toru M
Eur J Pharmacol; 1983 Mar; 88(2-3):195-203. PubMed ID: 6133769
[TBL] [Abstract][Full Text] [Related]
8. Two dopamine receptors: supportive evidence with the rat rotational model.
Tye NC; Horsman L; Wright FC; Large BT; Pullar IA
Eur J Pharmacol; 1977 Sep; 45(1):87-90. PubMed ID: 560970
[TBL] [Abstract][Full Text] [Related]
9. Cytidine(5')diphosphocholine enhances the ability of haloperidol to increase dopamine metabolites in the striatum of the rat and to diminish stereotyped behavior induced by apomorphine.
Agut J; Coviella IL; Wurtman RJ
Neuropharmacology; 1984 Dec; 23(12A):1403-6. PubMed ID: 6543245
[TBL] [Abstract][Full Text] [Related]
10. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
De Veaugh-Geiss J; Devanand DP; Carey RJ
Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
[TBL] [Abstract][Full Text] [Related]
11. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.
Clarke PB; Wyder KJ; Jakubovic A; Fibiger HC
Br J Pharmacol; 1990 Mar; 99(3):509-15. PubMed ID: 2110017
[TBL] [Abstract][Full Text] [Related]
12. Alteration of striatal dopaminergic functions implicated in methamphetamine-induced reverse tolerance in rats.
Kaneno S; Watanabe A; Takahashi R
Eur J Pharmacol; 1986 Apr; 123(2):287-94. PubMed ID: 3086109
[TBL] [Abstract][Full Text] [Related]
13. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
Nomura Y; Komori T; Okuda S; Segawa T
Arch Int Pharmacodyn Ther; 1979 Jan; 237(1):25-30. PubMed ID: 485682
[TBL] [Abstract][Full Text] [Related]
14. Effect of mecamylamine on the fate of dopamine in striatal and mesolimbic areas of rat brain; interaction with morphine and haloperidol.
Ahtee L; Kaakkola S
Br J Pharmacol; 1978 Feb; 62(2):213-8. PubMed ID: 564219
[TBL] [Abstract][Full Text] [Related]
15. Apomorphine- and haloperidol-induced change in 3,4-dihydroxyphenylacetic acid content in the mesolimbic-striatum of the developing rat.
Nomura Y; Oki K; Segawa T
J Pharmacobiodyn; 1980 Feb; 3(2):111-6. PubMed ID: 7205536
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine.
Sayers AC; Bürki HR; Ruch W; Asper H
Psychopharmacologia; 1975; 41(2):97-104. PubMed ID: 1171492
[TBL] [Abstract][Full Text] [Related]
17. Effects of the l isomer of fenfluramine on dopamine mechanisms in rat brain: further studies.
Invernizzi R; Bertorelli R; Consolo S; Garattini S; Samanin R
Eur J Pharmacol; 1989 May; 164(2):241-8. PubMed ID: 2759175
[TBL] [Abstract][Full Text] [Related]
18. Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment.
Wheeler SC; Roth RH
Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):151-9. PubMed ID: 7190650
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic haloperidol and quinacrine coadministration on striatal HVA levels and stereotypic behaviors in response to apomorphine in the rat.
Deutsch SI; Halperin R; Stanley M; Davis KL
Neurochem Res; 1985 Apr; 10(4):491-8. PubMed ID: 2582289
[TBL] [Abstract][Full Text] [Related]
20. The interaction of clonidine with dopamine-dependent behaviour in rodents.
Pycock CJ; Jenner PG; Marsden CD
Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):133-41. PubMed ID: 558529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
